Safety study of an experimental drug in healthy adults
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You weigh at least 45 kg (females) or 50 kg (males), with a body mass index (BMI) between 18.0 and 26.0.
- You are generally healthy, with normal or acceptable results on heart, lung, and lab tests.
- You have not taken any prescription drugs, over-the-counter medicines, herbal supplements, or vitamins in the 4 weeks before the study.
- You do not smoke more than 5 cigarettes a day and are willing to avoid alcohol, tobacco, and certain foods (like grapefruit, coffee, tea) during the study.
- You agree to use effective non-hormonal birth control (or have had sterilization) and not donate sperm or eggs during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.